Trial
NCT03195088
Evaluation of Safety and Tolerability of Single Rising Doses of BI 473494 in Healthy Subjects
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Healthy
Intervention
BI 473494
Why stopped
Terminated (Business Reasons)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-14